Skip to content
Virpax Pharmaceuticals Logo
  • HOME
  • ABOUT
  • PRODUCTS
    • PORTFOLIO
    • GLOBAL SUBLICENSING
    • BEHIND THE SCIENCE
    • PUBLICATIONS
  • TEAM
  • INVESTORS
  • RECENT MEDIA
  • CONTACT
  • HOME
  • ABOUT
  • PRODUCTS
    • PORTFOLIO
    • GLOBAL SUBLICENSING
    • BEHIND THE SCIENCE
    • PUBLICATIONS
  • TEAM
  • INVESTORS
  • RECENT MEDIA
  • CONTACT
Virpax Pharmaceuticals Logo
  • HOME
  • ABOUT
  • PRODUCTS
    • PORTFOLIO
    • GLOBAL SUBLICENSING
    • BEHIND THE SCIENCE
    • PUBLICATIONS
  • TEAM
  • INVESTORS
  • RECENT MEDIA
  • CONTACT
Altasciences Chosen by Virpax to Support the Development of a New Drug to Prevent Spread of Flu-like Viruses

Sep 21, 2023

Altasciences Chosen by Virpax to Support the Development of a New Drug to Prevent Spread of Flu-like Viruses

admin2023-09-21T22:24:13-04:00September 21st, 2023|Media|
Virpax Pharma new pain management

NASDAQ: VRPX

Corporate Headquarters
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312

Phone 610.727.4597
Email info@virpaxpharma.com

Virpax Pharma new pain management

NASDAQ: VRPX

Corporate Headquarters
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312

Phone 610.727.4597
Email info@virpaxpharma.com

  • HOME
  • ABOUT
  • PRODUCTS
  • TEAM
  • INVESTORS
  • RECENT MEDIA
  • CONTACT
  • GLOBAL SUBLICENSING
  • BEHIND THE SCIENCE
  • PUBLICATIONS

© Virpax® Pharmaceuticals. All Rights Reserved.

© Virpax® Pharmaceuticals. All Rights Reserved.

Follow @VirpaxPharma
Follow @VirpaxPharma
Page load link
Go to Top